Standout Papers

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders 2005 2026 2012 2019 2.5k
  1. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005)
    E. Joanna Baxter, Linda M. Scott et al. The Lancet
  2. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders (2005)
    E. Joanna Baxter, Linda M. Scott et al. The Lancet

Immediate Impact

3 by Nobel laureates 31 from Science/Nature 85 standout
Sub-graph 1 of 19

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
2024 StandoutNature
4 intermediate papers

Works of S Swanton being referenced

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout

Author Peers

Author Last Decade Papers Cites
S Swanton 2194 3047 1274 1841 11 3.6k
Nasios Fourouclas 2048 3023 1277 1833 8 3.5k
Elaine Boyd 2336 3611 1539 2204 9 4.1k
Clare East 2676 4114 1768 2530 12 4.6k
Jean‐Pierre Le Couedic 2107 2373 962 1609 18 3.6k
Natasha Joan Curtin 1987 2969 1255 1752 6 3.4k
Shu Tamura 2508 1591 1120 1019 12 3.7k
Ralph Tiedt 2336 2795 1108 2261 33 4.4k
Catherine Lacout 2545 3221 1238 2129 47 4.2k
Yana Pikman 1791 2001 698 1488 40 2.6k
Amy V. Jones 1856 1985 860 1971 43 3.2k

All Works

Loading papers...

Rankless by CCL
2026